Literature DB >> 11328785

SHV-type extended-spectrum beta-lactamase in a Shigella flexneri clinical isolate.

N Fortineau1, T Naas, O Gaillot, P Nordmann.   

Abstract

A Shigella flexneri isolate resistant to oxyimino-cephalosporins was recovered from a stool sample of a 16 month-old Algerian child hospitalized in Paris, France. This isolate harboured an SHV-2 beta-lactamase gene located on a c. 80 kb self-transferable plasmid. This is the first report of an Ambler class A extended-spectrum beta-lactamase from Shigella spp.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11328785     DOI： 10.1093/jac/47.5.685

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  19 in total

1.  bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates.

Authors:  David S Hammond; Jacqueline M Schooneveldt; Graeme R Nimmo; Flavia Huygens; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  SHV-49, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Klebsiella pneumoniae.

Authors:  Véronique Dubois; Laurent Poirel; Corinne Arpin; Laure Coulange; Cécile Bebear; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Mosaic structure of p1658/97, a 125-kilobase plasmid harboring an active amplicon with the extended-spectrum beta-lactamase gene blaSHV-5.

Authors:  M Zienkiewicz; I Kern-Zdanowicz; M Gołebiewski; J Zyliñska; P Mieczkowski; M Gniadkowski; J Bardowski; P Cegłowski
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

4.  High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.

Authors:  Sumathi Sivapalasingam; Jennifer M Nelson; Kevin Joyce; Mike Hoekstra; Frederick J Angulo; Eric D Mintz
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011.

Authors:  D Bhattacharya; H Bhattacharya; R Thamizhmani; D S Sayi; R Reesu; M Anwesh; C Kartick; A P Bharadwaj; M Singhania; A P Sugunan; S Roy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-29       Impact factor: 3.267

6.  Molecular characterization of the extended-spectrum beta-lactamase (ESBL)-producing Shigella spp. in Shanghai.

Authors:  J Li; B Li; Y Ni; J Sun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-25       Impact factor: 3.267

7.  Emergence of ceftriaxone resistant Shigella.

Authors:  Neeraj Goel; Chand Wattal; Dinesh Kaul; V K Khanna
Journal:  Indian J Pediatr       Date:  2011-12-29       Impact factor: 1.967

8.  Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei.

Authors:  I-Fei Huang; Cheng-Hsun Chiu; Mei-Hui Wang; Chan-Yao Wu; Kai-Sheng Hsieh; Christine C Chiou
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 9.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

10.  Antimicrobial resistance among Salmonella and Shigella isolates in five Canadian provinces (1997 to 2000).

Authors:  Leah J Martin; James Flint; André Ravel; Lucie Dutil; Kathryn Doré; Marie Louie; Frances Jamieson; Sam Ratnam
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-07       Impact factor: 2.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.